The Leukemia & Lymphoma Society's New Investigator Research Grant Program funds early-career scientists conducting innovative research on leukemia and myelodysplastic syndromes.
Funder: Leukemia & Lymphoma Society
Due Dates: February 5, 2027: Letter of Intent (LOI) submission deadline (due by 12:00 PM CT) | April 12, 2027: Full application submission deadline (if invited; due by 12:00 PM CT)
Funding Amounts: Up to $150,000 total over 2 years; no indirect costs or PI salary support.
Summary: Supports early-career independent investigators pursuing innovative research projects in leukemia and myelodysplastic syndromes.
Key Information: Applicants must have less than $175K/year in active direct costs and be within 7 years of first faculty appointment.
This program funds new independent investigators aiming to advance research in leukemia and related disorders, including myelodysplastic syndromes (MDS). The grant is designed to help early-career scientists establish their research programs and make significant contributions to the field. Projects should be innovative, with the potential for meaningful scientific impact.